Sarepta Therapeutics, Inc.
SRPT
$20.22
$0.160.80%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 53.06% | -61.41% | 13.05% | -17.95% | 5.01% |
Total Receivables | -15.86% | 11.51% | 25.92% | 31.54% | -6.47% |
Inventory | 5.59% | 25.53% | 32.52% | 16.49% | 30.06% |
Prepaid Expenses | 16.89% | -4.44% | -2.77% | -7.88% | -0.22% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 2.07% | -25.60% | -22.81% | 20.16% | 25.91% |
Total Current Assets | 9.23% | -20.85% | 14.45% | 0.06% | 8.88% |
|
|||||
Total Current Assets | 9.23% | -20.85% | 14.45% | 0.06% | 8.88% |
Net Property, Plant & Equipment | 1.43% | 3.89% | 9.39% | 11.62% | 6.56% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 16.50% | -2.56% | -2.48% | -2.41% | -2.34% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -36.17% | 63.25% | -6.51% | -16.66% | -2.90% |
Total Assets | 6.19% | -12.56% | 10.09% | 5.13% | 6.20% |
|
|||||
Total Accounts Payable | -12.43% | -27.20% | 80.55% | 10.57% | 17.35% |
Total Accrued Expenses | 14.81% | -26.02% | 11.57% | 4.94% | 32.12% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -19.72% | -2.25% | -87.81% | 0.23% | -10.85% |
Total Finance Division Other Current Liabilities | 120.22% | -1.74% | 2.77% | -4.06% | 11.27% |
Total Other Current Liabilities | 120.22% | -1.74% | 2.77% | -4.06% | 11.27% |
Total Current Liabilities | 51.91% | -17.23% | 4.60% | 1.60% | 13.11% |
|
|||||
Total Current Liabilities | 51.91% | -17.23% | 4.60% | 1.60% | 13.11% |
Long-Term Debt | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 4.36% | 6.75% | 13.21% | 18.39% | 2.50% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -86.98% | -0.22% | 0.20% | -1.81% | -0.11% |
Total Liabilities | -0.01% | -4.63% | 2.38% | 1.35% | 3.71% |
|
|||||
Common Stock & APIC | 0.74% | 1.08% | 2.69% | 1.95% | 2.04% |
Retained Earnings | 4.23% | -10.63% | 3.64% | 0.76% | 0.15% |
Treasury Stock & Other | -74,552.94% | 115.60% | -109.71% | 317.96% | -49.06% |
Total Common Equity | 18.79% | -25.20% | 25.11% | 13.37% | 12.06% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 18.79% | -25.20% | 25.11% | 13.37% | 12.06% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 18.79% | -25.20% | 25.11% | 13.37% | 12.06% |
|